serval:BIB_01EC47B892C7
Stereotactic Radiotherapy for the Management of Refractory Ventricular Tachycardia: Promise and Future Directions.
10.3389/fcvm.2020.00108
32671101
Jumeau
R.
author
Ozsahin
M.
author
Schwitter
J.
author
Elicin
O.
author
Reichlin
T.
author
Roten
L.
author
Andratschke
N.
author
Mayinger
M.
author
Saguner
A.M.
author
Steffel
J.
author
Blanck
O.
author
Vozenin
M.C.
author
Moeckli
R.
author
Zeverino
M.
author
Vallet
V.
author
Herrera-Siklody
C.
author
Pascale
P.
author
Bourhis
J.
author
Pruvot
E.
author
article
review
2020
Frontiers in cardiovascular medicine
2297-055X
2297-055X
journal
7
108
Ventricular tachycardia (VT) caused by myocardial scaring bears a significant risk of mortality and morbidity. Antiarrhythmic drug therapy (AAD) and catheter ablation remain the cornerstone of VT management, but both treatments have limited efficacy and potential adverse effects. Stereotactic body radiotherapy (SBRT) is routinely used in oncology to treat non-invasively solid tumors with high precision and efficacy. Recently, this technology has been evaluated for the treatment of VT. This review presents the basic underlying principles, proof of concept, and main results of trials and case series that used SBRT for the treatment of VT refractory to AAD and catheter ablation.
ablation
noninvasive
radiotherapy
stereotactic radiotherapy
ventricular tachycardia
eng
60_published
true
peer-reviewed
Publication types: Journal Article ; Review
Publication Status: epublish
University of Lausanne
mailto:serval_help@unil.ch
http://www.unil.ch/serval
http://serval.unil.ch/disclaimer
https://serval.unil.ch/notice/serval:BIB_01EC47B892C7